Health Care & Life Sciences » Pharmaceuticals | Tonghua Dongbao Pharmaceutical Co. Ltd.

Tonghua Dongbao Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,196
1,440
1,664
2,021
2,528
2,673
Cost of Goods Sold (COGS) incl. D&A
418
487
448
549
702
823
Gross Income
778
953
1,216
1,472
1,827
1,849
SG&A Expense
556
599
641
657
838
884
EBIT
219
348
566
807
981
960
Non Operating Income/Expense
3
6
32
14
11
16
Interest Expense
18
28
19
45
16
13
Pretax Income
203
318
585
781
967
982
Income Tax
32
47
80
120
133
139
Equity in Affiliates
9
6
15
22
6
5
Consolidated Net Income
179
277
490
639
840
839
Net Income
184
280
493
641
837
839
Net Income After Extraordinaries
184
280
493
641
837
839
Net Income Available to Common
184
280
493
641
837
839
EPS (Basic)
0.10
0.14
0.25
0.32
0.41
0.41
Basic Shares Outstanding
1,948
1,958
1,963
2,006
2,049
2,045
EPS (Diluted)
0.09
0.14
0.25
0.32
0.41
0.41
Diluted Shares Outstanding
1,948
1,958
1,963
2,006
2,049
2,045
EBITDA
328
462
698
967
1,148
1,131
Other Operating Expense
3
6
9
9
7
5
Non-Operating Interest Income
1
1
2
3
13
19
Minority Interest Expense
4
3
3
2
4
-

About Tonghua Dongbao Pharmaceutical Co.

View Profile
Address
Dongbao New Village
Tonghua Jilin 134123
China
Employees -
Website -
Updated 07/08/2019
Tonghua Dongbao Pharmaceutical Co., Ltd. is engaged in the manufacture, distribution, research and development of pharmaceuticals. Its main products include hard capsules, tablets, granules, small volume injections, traditional Chinese medicine, active pharmaceutical ingredients (recombinant human insulin) and bio-engineering products. The company also produces building materials such as plastic steel windows.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.